{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:15:22Z","timestamp":1795054522925,"version":"4.10.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009655","name":"Sunovion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010377","name":"National Institute for Health and Care Excellence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010872","name":"King&apos;s College Hospital NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012176","name":"Maudsley Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King&apos;s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Psychiatry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/s2215-0366(22)00188-2","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T18:34:40Z","timestamp":1656354880000},"page":"636-644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Relaxation of the criteria for entry to the UK Clozapine Central Non-Rechallenge Database: a modelling study"],"prefix":"10.1016","volume":"9","author":[{"given":"Ebenezer","family":"Oloyede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eromona","family":"Whiskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Casetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubanke","family":"Dzahini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Dunnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyans","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Gaughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhi","family":"Shergill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H","family":"MacCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2215-0366(22)00188-2_bib1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/schbul\/sbab006","article-title":"There is life after the UK clozapine central non-rechallenge database","volume":"47","author":"Oloyede","year":"2021","journal-title":"Schizophr Bull"},{"key":"10.1016\/S2215-0366(22)00188-2_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.seminhematol.2013.06.010","article-title":"Evaluation and management of patients with isolated neutropenia","volume":"50","author":"Newburger","year":"2013","journal-title":"Semin Hematol"},{"key":"10.1016\/S2215-0366(22)00188-2_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.2.4883.358-c","article-title":"Chlorpromazine and agranulocytosis","volume":"2","author":"Lomas","year":"1954","journal-title":"BMJ"},{"key":"10.1016\/S2215-0366(22)00188-2_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0957154X07070335","article-title":"The history of clozapine and its emergence in the US market: a review and analysis","volume":"18","author":"Crilly","year":"2007","journal-title":"Hist Psychiatry"},{"key":"10.1016\/S2215-0366(22)00188-2_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.12898","article-title":"Meta-analysis examining the epidemiology of clozapine-associated neutropenia","volume":"138","author":"Myles","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2215-0366(22)00188-2_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0004867419833166","article-title":"A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia","volume":"53","author":"Myles","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/S2215-0366(22)00188-2_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1192\/bjb.2018.67","article-title":"Barriers to using clozapine in treatment-resistant schizophrenia: systematic review","volume":"43","author":"Farooq","year":"2019","journal-title":"BJPsych Bull"},{"key":"10.1016\/S2215-0366(22)00188-2_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/acps.13280","article-title":"An evaluation of the variation and underuse of clozapine in the United Kingdom","volume":"143","author":"Whiskey","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2215-0366(22)00188-2_bib9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1192\/bjp.175.6.576","article-title":"Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance","volume":"175","author":"Munro","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2215-0366(22)00188-2_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/schbul\/sbab103","article-title":"Reducing the risk of withdrawal symptoms and relapse following clozapine discontinuation\u2014is it feasible to develop evidence-based guidelines?","volume":"48","author":"Blackman","year":"2021","journal-title":"Schizophr Bull"},{"key":"10.1016\/S2215-0366(22)00188-2_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wps.20699","article-title":"20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)","volume":"19","author":"Taipale","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/S2215-0366(22)00188-2_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2215-0366(22)00188-2_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12888-021-03514-6","article-title":"Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals","volume":"21","author":"Oloyede","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/S2215-0366(22)00188-2_bib14","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.4088\/JCP.16m11152","article-title":"Evaluating the effect of the changes in FDA guidelines for clozapine monitoring","volume":"78","author":"Sultan","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S2215-0366(22)00188-2_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.9740\/mhc.2018.03.063","article-title":"Assessing prescribing practices of clozapine before and after the implementation of an updated risk evaluation and mitigation strategy","volume":"8","author":"Curry","year":"2018","journal-title":"Ment Health Clin"},{"key":"10.1016\/S2215-0366(22)00188-2_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.9740\/mhc.2020.05.070","article-title":"Clozapine and hematologic adverse reactions: impact of the Risk Evaluation and Mitigation Strategy program","volume":"10","author":"Borrelli","year":"2020","journal-title":"Ment Health Clin"},{"key":"10.1016\/S2215-0366(22)00188-2_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4088\/JCP.11m07244","article-title":"Clozapine-induced agranulocytosis in Finland, 1982\u20132007: long-term monitoring of patients is still warranted","volume":"73","author":"Lahdelma","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S2215-0366(22)00188-2_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41537-022-00232-0","article-title":"Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis","volume":"8","author":"Taylor","year":"2022","journal-title":"NPJ Schizophr"},{"key":"10.1016\/S2215-0366(22)00188-2_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3109\/08039488.2016.1155234","article-title":"Clozapine treatment and discontinuation in Iceland: a national longitudinal study using electronic patient records","volume":"70","author":"Ingimarsson","year":"2016","journal-title":"Nord J Psychiatry"},{"key":"10.1016\/S2215-0366(22)00188-2_bib20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/pgmj.2004.031161","article-title":"Clozapine, agranulocytosis, and benign ethnic neutropenia","volume":"81","author":"Rajagopal","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1016\/S2215-0366(22)00188-2_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2011.10.014","article-title":"When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature","volume":"134","author":"Manu","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(22)00188-2_bib22","doi-asserted-by":"crossref","first-page":"e1410","DOI":"10.4088\/JCP.14m09326","article-title":"Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis","volume":"76","author":"Meyer","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S2215-0366(22)00188-2_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40263-016-0311-1","article-title":"Worldwide differences in regulations of clozapine use","volume":"30","author":"Nielsen","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/S2215-0366(22)00188-2_bib24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1176\/appi.ajp.2012.12081036","article-title":"White blood cell monitoring during long-term clozapine treatment","volume":"170","author":"Cohen","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2215-0366(22)00188-2_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211032053","article-title":"Clozapine discontinuation withdrawal symptoms in schizophrenia","volume":"11","author":"Blackman","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/S2215-0366(22)00188-2_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.200061","article-title":"Consensus statement on the use of clozapine during the COVID-19 pandemic","volume":"45","author":"Siskind","year":"2020","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/S2215-0366(22)00188-2_bib27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1017\/S0033291719000369","article-title":"The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies","volume":"50","author":"Li","year":"2020","journal-title":"Psychol Med"},{"key":"10.1016\/S2215-0366(22)00188-2_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/FTD.0000000000000711","article-title":"Clozapine and norclozapine plasma levels in patients switched between different liquid formulations","volume":"42","author":"Oloyede","year":"2020","journal-title":"Ther Drug Monit"},{"key":"10.1016\/S2215-0366(22)00188-2_bib29","doi-asserted-by":"crossref","first-page":"E232","DOI":"10.1503\/jpn.200208","article-title":"COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine","volume":"46","author":"Gee","year":"2021","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/S2215-0366(22)00188-2_bib30","first-page":"E003-E","article-title":"Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19","volume":"59","author":"Li","year":"2020","journal-title":"Zhonghua Nei Ke Za Zhi"}],"container-title":["The Lancet Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215036622001882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215036622001882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:20:31Z","timestamp":1762410031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2215036622001882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2215036622001882"],"URL":"https:\/\/doi.org\/10.1016\/s2215-0366(22)00188-2","relation":{},"ISSN":["2215-0366"],"issn-type":[{"value":"2215-0366","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relaxation of the criteria for entry to the UK Clozapine Central Non-Rechallenge Database: a modelling study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2215-0366(22)00188-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}